Skip to main content
. 2021 Sep 16;149:e210. doi: 10.1017/S0950268821002119

Table 4.

Patient PCR data, symptoms and prevalence

Group I (n = 1273) Group II (n = 476)
Preoperative period
The number of PCR test, n (%)
Total 232 (18.2) 110 (23.1)
Positive 15 (6.5) 2 (1.8)
The number of CT, n (%)
Total 151 (11.9) 78 (16.4)
Positive infiltration 34 (22.5) 26 (30.8)
Patients who have only clinical symptoms, n (%) 4 (0.3) 0 (0.2)
Treated patients, n (%) 39 (3.1) 28 (5.9)
Prevalence (%) 3.1 5.9
Symptoms, n (%)
Cough 18 (46.2) 7 (28.0)
Fever 14 (35.9) 5 (20.0)
Arthralgia 8 (20.5) 3 (12.0)
Throat ache 3 (7.7) 1 (4.0)
Neurological findings 2 (5.1) 1 (4.0)
Diarrhoea 2 (5.1) 1 (4.0)
Anosmia 1 (2.6) 0 (0.0)
Postoperative period
Group I (n = 1273) Group II (n = 476)
The number of PCR test, n (%)
Total 47 (3.7) 18 (3.8)
Positive 2 (4.3) 2 (11.1)
The number of CT, n (%)
Total 19 (3.0) 18 (4.2)
Positive infiltration 3 (15.8) 1 (5.6)
Patients who have only clinical symptoms, n (%) 1 (0.1) 0 (0.0)
Treated patients, n (%) 4 (0.3) 2 (0.4)
Prevalence (%) 0.3 0.4
Symptoms, n (%)
Cough 3 (75.0) 2 (100.0)
Fever 2 (50.0) 1 (50.0)
Arthralgia 1 (25.0) 1 (50.0)
Throat ache 0 (0.0) 0 (0.0)
Neurological findings 0 (0.0) 0 (0.0)
Diarrhoea 0 (0.0) 0 (0.0)
Anosmia 0 (0.0) 0 (0.0)

Group II, intervention patients; group I, surgical patients; CT, computed tomography; PCR, polymerase chain reaction.